Daniel Donnelly holds a Doctor of Philosophy - PhD in Chemistry from Northeastern University. With experience at Merck as a Senior Scientist and currently serving as a Senior Scientist and Principal Scientist at Alnylam Pharmaceuticals, Daniel brings a wealth of expertise to the field. Education-wise, Daniel also holds Bachelor's degrees from Salem State University and New York University.
July, 2023 - present
September, 2021